Ocular Therapeutix SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 16, 2026, 4:15 p.m. ETView on SEC.gov
Departure/appointment of directors or officers
AI summary, unreviewedOcular Therapeutix Chief Strategy Officer Sanjay Nayak Resigns Effective October 16, 2026 to Join Private Company
8-KAug. 3, 2026, 7:07 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits